How Can SimplePills Cover U.S. Pharmaceutical Tariffs When Some Can Reach 100%?

The 100% headline needs some context

Recent headlines about a 100% U.S. tariff on pharmaceutical products can understandably sound as though every medication entering the United States is now subject to a 100% tariff.

That is not the case. Some medications can face a 100% tariff, some face a lower rate, and some remain at 0%.

The U.S. government has imposed a Section 232 tariff on certain patented pharmaceutical products and ingredients. The stated goal is to reduce U.S. reliance on foreign pharmaceutical manufacturing and encourage more production in the United States.

So while “100% pharmaceutical tariff” makes a strong headline, the actual tariff on an individual medication depends on the specific product and the rules that apply to it.

Why tariff rates vary by medication

There is no single tariff code or tariff rate for “medication.” Medicines and pharmaceutical ingredients are classified under many different HTSUS codes — the product codes U.S. Customs uses to identify imported goods.

The final tariff treatment can depend on several things, including:

whether the medication is patented or generic;
its HTSUS classification;
where it was made;
the manufacturer and any qualifying U.S. onshoring or pricing agreement; and
whether the product falls into an exempt category.

For example, generic pharmaceuticals and biosimilars are not subject to the new Section 232 pharmaceutical tariff at this time. Some covered patented products can face a 100% combined duty rate, while others may qualify for 20%, 15%, or 0% treatment.

So “100% tariff on pharmaceuticals” does not mean “100% tariff on every prescription medication.”

What about medication ordered for personal use?

The policy is mainly aimed at pharmaceutical manufacturing and commercial supply chains. However, the tariff rules do not create a broad exemption simply because an individual patient is ordering medication for personal use through the mail.

That means a personal-use medication shipment can still be affected by the applicable tariff rules, even though it is very different from a pharmaceutical company importing commercial inventory.

This is also separate from the FDA's personal importation policy. FDA rules address whether a medication shipment may be admitted from a regulatory perspective. Customs tariff rules determine what duty may apply. They are two different parts of the import process.

Why SimplePills is still covering tariffs

SimplePills continues to cover applicable U.S. tariff costs instead of adding them to the price patients pay. Tariffs create a real additional cost, and the amount can vary from one medication to another. We are working to absorb those costs by simplifying operations, automating repetitive work, and using technology to make our pharmacy and shipping processes more efficient.

We are doing this because medication is different from most imported products. Many patients come to us because the U.S. price of a prescribed medication is difficult to afford, and ordering from Canada may be one of the few practical ways to access it within their budget. We know these savings matter, and we do not want new tariff costs to take them away. Tariff policy may also change over time, so rather than treating the current situation as a permanent reason to raise prices, we are managing it as a cost we need to work through with our patients.

The bottom line

The 100% pharmaceutical tariff is real, but it does not apply to every medication. The actual rate can depend on the medication, its classification, origin, manufacturer, and applicable exemptions or agreements.

Personal-use shipments are not automatically excluded from those rules. SimplePills is continuing to manage the added complexity on our side and, at this time, we are not passing applicable U.S. tariff costs on to our patients.